Skip to Content

par 545 (Ranitidine 300 mg)

Pill with imprint par 545 is Yellow, Elliptical / Oval and has been identified as Ranitidine hydrochloride 300 mg. It is supplied by Par Pharmaceutical Inc..

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for par 545

Ranitidine hydrochloride 300 mg par 545  Front
Ranitidine hydrochloride 300 mg par 545  Back
Ranitidine hydrochloride 300 mg par 545
Ranitidine hydrochloride 300 mg par 545

Ranitidine hydrochloride

par 545
300 mg
14.00 mm
Elliptical / Oval
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Par Pharmaceutical Inc.
Inactive Ingredients:
FD&C Yellow No. 6
lactose monohydrate
magnesium stearate
microcrystalline cellulose
pregelatinized corn starch
titanium dioxide
triethyl citrate
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.